Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Disc Medicine, Inc. | Chief Executive Officer, Director | Common Stock | 72.1K | $3.35M | $46.45 | Jul 8, 2024 | Direct |
Disc Medicine, Inc. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 238K | Jul 8, 2024 | Direct | ||
Gossamer Bio, Inc. | Director | Non-qualified stock option (Right to Buy) | 115K | Jun 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IRON | Disc Medicine, Inc. | Jul 8, 2024 | 2 | $3.03K | 4 | Jul 10, 2024 | Chief Executive Officer, Director |
GOSS | Gossamer Bio, Inc. | Jun 6, 2024 | 1 | $0 | 4 | Jun 6, 2024 | Director |
IRON | Disc Medicine, Inc. | Jan 10, 2024 | 2 | $0 | 4 | Mar 1, 2024 | Chief Executive Officer, Director |
IRON | Disc Medicine, Inc. | Dec 29, 2023 | 2 | $2.73K | 4 | Jan 3, 2024 | Chief Executive Officer, Director |
GOSS | Gossamer Bio, Inc. | Nov 28, 2023 | 1 | $0 | 4 | Nov 29, 2023 | Director |
GOSS | Gossamer Bio, Inc. | Nov 28, 2023 | 0 | $0 | 3 | Nov 29, 2023 | Director |
IRON | Disc Medicine, Inc. | Dec 29, 2022 | 1 | $0 | 4 | Jan 3, 2023 | Chief Executive Officer, Director |
IRON | Disc Medicine, Inc. | Dec 29, 2022 | 0 | $0 | 3 | Jan 3, 2023 | Chief Executive Officer, Director |